Newman LS, Rose CS, Maier LA (1997) Sarcoidosis. N Engl J Med 336:1224–1234. https://doi.org/10.1056/NEJM199704243361706
CAS Article PubMed Google Scholar
Iannuzzi MC, Rybicki BA, Teirstein AS (2007) Sarcoidosis. N Engl J Med 357:2153–2165. https://doi.org/10.1056/NEJMra071714
CAS Article PubMed Google Scholar
Hillerdal G, Nou E, Osterman K et al (1984) Sarcoidosis: epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis 130:29–32. https://doi.org/10.1164/arrd.1984.130.1.29
CAS Article PubMed Google Scholar
Rybicki BA, Major M, Popovich J et al (1997) Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 145:234–241. https://doi.org/10.1093/oxfordjournals.aje.a009096
CAS Article PubMed Google Scholar
Rothova A (2000) Ocular involvement in sarcoidosis. Br J Ophthalmol 84:110–116. https://doi.org/10.1136/bjo.84.1.110
CAS Article PubMed PubMed Central Google Scholar
Nagata K, Maruyama K, Sugita S et al (2014) Age differences in sarcoidosis patients with posterior ocular lesions. Ocul Immunol Inflamm 22:257–262. https://doi.org/10.3109/09273948.2013.855796
Takayama K, Harimoto K, Sato T et al (2018) Age-related differences in the clinical features of ocular sarcoidosis. PLoS ONE 13:e0202585. https://doi.org/10.1371/journal.pone.0202585
CAS Article PubMed PubMed Central Google Scholar
Morimoto T, Azuma A, Abe S et al (2008) Epidemiology of sarcoidosis in Japan. Eur Respir J 31:372–379. https://doi.org/10.1183/09031936.00075307
CAS Article PubMed Google Scholar
Herbort CP, Rao NA, Mochizuki M (2009) International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm 17:160–169. https://doi.org/10.1080/09273940902818861
CAS Article PubMed Google Scholar
Acharya NR, Browne EN, Rao N et al (2018) Distinguishing features of ocular sarcoidosis in an international cohort of uveitis patients. Ophthalmology 125:119–126. https://doi.org/10.1016/j.ophtha.2017.07.006
Mochizuki M, Smith JR, Takase H et al (2019) Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. Br J Ophthalmol 103:1418–1422. https://doi.org/10.1136/bjophthalmol-2018-313356
Lobo A, Barton K, Minassian D et al (2003) Visual loss in sarcoid-related uveitis. Clin Exp Ophthalmol 31:310–316. https://doi.org/10.1046/j.1442-9071.2003.00666.x
Rochepeau C, Jamilloux Y, Kerever S et al (2017) Long-term visual and systemic prognoses of 83 cases of biopsy-proven sarcoid uveitis. Br J Ophthalmol 101:856–861. https://doi.org/10.1136/bjophthalmol-2016-309767
Dana MR, Merayo-Lloves J, Schaumberg DA et al (1996) Prognosticators for visual outcome in sarcoid uveitis. Ophthalmology 103:1846–1853. https://doi.org/10.1016/s0161-6420(96)30417-x
CAS Article PubMed Google Scholar
Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140:509–516. https://doi.org/10.1016/j.ajo.2005.03.057
Sonoda KH, Hasegawa E, Namba K et al (2021) Epidemiology of uveitis in Japan: a 2016 retrospective nationwide survey. Jpn J Ophthalmol 65:184–190. https://doi.org/10.1007/s10384-020-00809-1
Handa-Miyauchi M, Takase H, Tanaka Akiyama M et al (2020) A validation study of the revised diagnostic criteria from the International Workshop on Ocular Sarcoidosis at a single institute in Japan. Ocul Immunol Inflamm. https://doi.org/10.1080/09273948.2020.1758159
Baughman RP, Teirstein AS, Judson MA et al (2001) Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 164:1885–1889. https://doi.org/10.1164/ajrccm.164.10.2104046
CAS Article PubMed Google Scholar
Gribbin J, Hubbard RB, Le Jeune I et al (2006) Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 61:980–985. https://doi.org/10.1136/thx.2006.062836
CAS Article PubMed PubMed Central Google Scholar
Keino H, Nakashima C, Watanabe T et al (2009) Frequency and clinical features of intraocular inflammation in Tokyo. Clin Exp Ophthalmol 37:595–601. https://doi.org/10.1111/j.1442-9071.2009.02102.x
Shirai M, Sato A, Chida K (1995) The influence of ovarian hormones on the granulomatous inflammatory process in the rat lung. Eur Respir J 8:272–277. https://doi.org/10.1183/09031936.95.08020272
CAS Article PubMed Google Scholar
Tajima K, Miura K, Ishiwata T et al (2011) Sex hormones alter Th1 responses and enhance granuloma formation in the lung. Respiration 81:491–498. https://doi.org/10.1159/000324295
CAS Article PubMed Google Scholar
Cozier YC, Berman JS, Palmer JR et al (2012) Reproductive and hormonal factors in relation to incidence of sarcoidosis in US Black women: The Black Women’s Health Study. Am J Epidemiol 176:635–641. https://doi.org/10.1093/aje/kws145
Article PubMed PubMed Central Google Scholar
Jamilloux Y, Kodjikian L, Broussolle C et al (2014) Sarcoidosis and uveitis. Autoimmun Rev 13:840–849. https://doi.org/10.1016/j.autrev.2014.04.001
Stegeman CA, Tervaert JW, Huitema MG et al (1993) Serum markers of T-cell activation in relapses of Wegener’s granulomatosis. Adv Exp Med Biol 336:389–392. https://doi.org/10.1007/978-1-4757-9182-2_67
CAS Article PubMed Google Scholar
Groen-Hakan F, Eurelings L, ten Berge JC et al (2017) Diagnostic value of serum-soluble interleukin 2 receptor levels vs angiotensin-converting enzyme in patients with sarcoidosis-associated uveitis. JAMA Ophthalmol 135:1352–1358. https://doi.org/10.1001/jamaophthalmol.2017.4771
Article PubMed PubMed Central Google Scholar
Shijubo N, Yamaguchi T (2015) Diagnosis criteria and classification of disease severity for sarcoidosis in Japan. Japanese J Sarcoidosis Other Granulomatous Disorders 35:3–8. https://doi.org/10.7878/jjsogd.35.3
Matsushima R, Usui Y, Umazume A et al (2019) Significance of serum-soluble interleukin-2 receptor level on the diagnosis of uveitis. J Jpn Ophthalmol Soc 2019(123):156–160
Takase H, Acharya NR, Babu K et al (2021) Recommendations for the management of ocular sarcoidosis from the International Workshop on Ocular Sarcoidosis. Br J Ophthalmol 105:1515–1519. https://doi.org/10.1136/bjophthalmol-2020-317354
Okada AA, Wakabayashi T, Morimura Y et al (2003) Trans-Tenon’s retrobulbar triamcinolone infusion for the treatment of uveitis. Br J Ophthalmol 87:968–971. https://doi.org/10.1136/bjo.87.8.968
CAS Article PubMed PubMed Central Google Scholar
Kempen JH, Altaweel MM, Drye LT et al (2015) Benefits of systemic anti-inflammatory therapy versus fluocinolone acetonide intraocular implant for intermediate uveitis, posterior uveitis, and panuveitis: fifty-four-month results of the Multicenter Uveitis Steroid Treatment (MUST) trial and follow-up study. Ophthalmology 122:1967–1975. https://doi.org/10.1016/j.ophtha.2015.06.042
留言 (0)